Payment overview · 2025
General Payments
$156.69
9 reported records · 1 companies
Healthcare provider profile · identity verified
Pinal Doshi, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · CERRITOS, CA · NPI 1326062712
Verified facts
What the public records show
CMS Open Payments records show Pinal Doshi, M.D. received $156.69 in general payments during 2025 across 9 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $156.69 | 100.0% | 9 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $156.69 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $156.69 | 9 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 848 | 255 |
| Amlodipine Besylate | Amlodipine Besylate | 447 | 133 |
| Metformin Hcl | Metformin Hcl | 433 | 137 |
| Losartan Potassium | Losartan Potassium | 383 | 118 |
| Levothyroxine Sodium | Levothyroxine Sodium | 302 | 82 |
| Furosemide | Furosemide | 253 | 96 |
| Glimepiride | Glimepiride | 246 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 243 | 71 |
| Lisinopril | Lisinopril | 227 | 63 |
| Tamsulosin Hcl | Tamsulosin Hcl | 201 | 64 |
| Alendronate Sodium | Alendronate Sodium | 171 | 59 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 168 | 58 |
| Finasteride | Finasteride | 160 | 52 |
| Gabapentin | Gabapentin | 159 | 51 |
| Simvastatin | Simvastatin | 156 | 43 |
| Omeprazole | Omeprazole | 150 | 55 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 147 | 49 |
| Jardiance | Empagliflozin | 134 | 33 |
| Carvedilol | Carvedilol | 128 | 38 |
| Celecoxib | Celecoxib | 117 | 46 |
| Pravastatin Sodium | Pravastatin Sodium | 108 | 36 |
| Pioglitazone Hcl | Pioglitazone Hcl | 107 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 104 | 51 |
| Diclofenac Sodium | Diclofenac Sodium | 93 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 91 | 28 |
| Eliquis | Apixaban | 87 | 26 |
| Montelukast Sodium | Montelukast Sodium | 84 | 30 |
| Allopurinol | Allopurinol | 83 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 83 | 28 |
| Trazodone Hcl | Trazodone Hcl | 82 | 26 |
| Benazepril Hcl | Benazepril Hcl | 80 | 24 |
| Atenolol | Atenolol | 76 | 24 |
| Pantoprazole Sodium | Pantoprazole Sodium | 75 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 73 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 72 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 71 | 24 |
| Potassium Chloride | Potassium Chloride | 71 | 24 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 69 | 22 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 66 | 21 |
| Farxiga | Dapagliflozin Propanediol | 65 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 64 | 22 |
| Nifedipine Er | Nifedipine | 63 | 19 |
| Mirtazapine | Mirtazapine | 62 | 22 |
| Ozempic | Semaglutide | 59 | suppressed |
| Meloxicam | Meloxicam | 57 | 17 |
| Ibuprofen | Ibuprofen | 56 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 55 | 19 |
| Prednisone | Prednisone | 52 | 32 |
| Glipizide | Glipizide | 50 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 50 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 49 | 34 |
| Valsartan | Valsartan | 49 | 13 |
| Clonidine Hcl | Clonidine Hcl | 48 | 21 |
| Bupropion Xl | Bupropion Hcl | 45 | 16 |
| Folic Acid | Folic Acid | 43 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 43 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 41 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 41 | 14 |
| Clobetasol Propionate | Clobetasol Propionate | 40 | 29 |
| Metformin Hcl Er | Metformin Hcl | 40 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 38 | 16 |
| Lovastatin | Lovastatin | 37 | 12 |
| Synjardy | Empagliflozin/Metformin Hcl | 36 | suppressed |
| Azithromycin | Azithromycin | 35 | 28 |
| Meclizine Hcl | Meclizine Hcl | 34 | 13 |
| Repaglinide | Repaglinide | 32 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 32 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 31 | suppressed |
| Famotidine | Famotidine | 31 | 17 |
| Felodipine Er | Felodipine | 31 | suppressed |
| Telmisartan | Telmisartan | 31 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 30 | suppressed |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 29 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Memantine Hcl | Memantine Hcl | 28 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 28 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 28 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Ezetimibe | Ezetimibe | 25 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 25 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 25 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 25 | 20 |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Latanoprost | Latanoprost | 24 | 11 |
| Methotrexate | Methotrexate Sodium | 24 | suppressed |
| Spironolactone | Spironolactone | 24 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 22 | 12 |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Levetiracetam | Levetiracetam | 21 | suppressed |
| Xarelto | Rivaroxaban | 21 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 20 | suppressed |
| Clonazepam | Clonazepam | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Metolazone | Metolazone | 17 | 11 |
| Dulera | Mometasone/Formoterol | 16 | suppressed |
| Tradjenta | Linagliptin | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | 15 |
| Donepezil Hcl | Donepezil Hcl | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Alprazolam | Alprazolam | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Mesalamine | Mesalamine | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 13 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | 12 |
| Calcitriol | Calcitriol | 12 | suppressed |
| Calcium Acetate | Calcium Acetate | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Neupro | Rotigotine | 12 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 12 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 11 | suppressed |
| Vascepa | Icosapent Ethyl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $156.69 · 9 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error